|
|
|
Insider
Information: |
Cohen Fred E |
Relationship: |
|
City: |
San Francisco |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
9 |
|
Direct
Shares |
366,218 |
|
Indirect Shares
|
4,593,263 |
|
|
Direct
Value |
$4,854,907 |
|
|
Indirect Value
|
$56,674,287 |
|
|
Total
Shares |
4,959,481 |
|
|
Total
Value |
$61,529,194 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
1
|
Stock
price went up :
|
0
|
1
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
Percentage
Gain/Loss : |
0.0%
|
216.8%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Genomic Health Inc |
GHDX |
Director |
2019-11-08 |
0 |
2019-11-08 |
0 |
Premium* |
|
Five Prime Therapeutics Inc |
FPRX |
Director |
2016-01-11 |
24,807 |
2014-07-01 |
0 |
Premium* |
|
Biocryst Pharmaceuticals Inc |
BCRX |
Director |
2017-09-18 |
119,410 |
2014-08-29 |
0 |
Premium* |
|
Caredx, Inc. |
CDNA |
Director |
2023-06-16 |
132,592 |
2014-10-01 |
0 |
Premium* |
|
Intellia Therapeutics, Inc. |
NTLA |
Director |
2023-06-14 |
41,716 |
2019-03-01 |
0 |
Premium* |
|
Urogen Pharma Ltd. |
URGN |
Director |
2019-02-06 |
15,000 |
2023-07-26 |
69,339 |
Premium* |
|
Veracyte, Inc. |
VCYT |
Director |
2020-10-19 |
10,000 |
2019-08-02 |
0 |
Premium* |
|
Progyny, Inc. |
PGNY |
Director |
2024-05-23 |
22,693 |
2020-10-24 |
0 |
Premium* |
|
Kyverna Therapeutics |
KYTX |
|
2024-02-12 |
0 |
2024-02-12 |
4,523,924 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
117 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 5
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BCRX |
Biocryst Pharmaceuticals ... |
Director |
|
2016-12-01 |
4 |
A |
$5.59 |
$9,995 |
D/D |
1,788 |
115,867 |
0 |
- |
|
CDNA |
Caredx, Inc. |
Director |
|
2017-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
3,391 |
22,630 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2017-01-01 |
4 |
A |
$29.39 |
$9,993 |
D/D |
340 |
65,578 |
0 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
Director |
|
2017-03-01 |
4 |
A |
$6.24 |
$9,996 |
D/D |
1,602 |
117,469 |
0 |
- |
|
CDNA |
Caredx, Inc. |
Director |
|
2017-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
5,271 |
27,901 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2017-04-01 |
4 |
A |
$31.49 |
$9,982 |
D/D |
317 |
65,895 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2017-05-16 |
4 |
S |
$30.68 |
$253,102 |
D/D |
(8,250) |
65,895 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2017-05-16 |
4 |
OE |
$18.13 |
$149,573 |
D/D |
8,250 |
74,145 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2017-05-18 |
4 |
OE |
$17.59 |
$297,743 |
D/D |
16,500 |
82,395 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2017-05-18 |
4 |
S |
$29.88 |
$493,040 |
D/D |
(16,500) |
65,895 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2017-05-19 |
4 |
S |
$29.54 |
$243,745 |
D/D |
(8,250) |
65,895 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2017-05-19 |
4 |
OE |
$14.37 |
$118,553 |
D/D |
8,250 |
74,145 |
0 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
Director |
|
2017-06-01 |
4 |
A |
$5.15 |
$9,996 |
D/D |
1,941 |
119,410 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2017-07-01 |
4 |
A |
$32.55 |
$9,993 |
D/D |
307 |
66,202 |
0 |
- |
|
CDNA |
Caredx, Inc. |
Director |
|
2017-07-13 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
32,901 |
0 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
Director |
|
2017-09-18 |
4 |
S |
$5.42 |
$294,035 |
D/D |
(54,250) |
119,410 |
0 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
Director |
|
2017-09-18 |
4 |
OE |
$4.27 |
$231,648 |
D/D |
54,250 |
173,660 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2017-10-01 |
4 |
A |
$32.09 |
$9,980 |
D/D |
311 |
66,513 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2018-01-01 |
4 |
A |
$34.20 |
$9,986 |
D/D |
292 |
66,805 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2018-04-01 |
4 |
A |
$31.29 |
$9,982 |
D/D |
319 |
67,124 |
0 |
- |
|
CDNA |
Caredx, Inc. |
Director |
|
2018-06-20 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
37,901 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2018-07-01 |
4 |
A |
$50.40 |
$9,979 |
D/D |
198 |
67,322 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2018-08-07 |
4 |
S |
$56.10 |
$463,800 |
D/D |
(8,250) |
67,322 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2018-08-07 |
4 |
OE |
$25.79 |
$212,768 |
D/D |
8,250 |
75,572 |
0 |
- |
|
CDNA |
Caredx, Inc. |
Director |
|
2018-08-28 |
4 |
OE |
$1.22 |
$18,300 |
D/D |
15,000 |
52,901 |
0 |
- |
|
117 Records found
|
|
Page 3 of 5 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|